HUMBERTO PAVON: Open Payments
NPI 1588661219 · NORFOLK, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,481 in 71 payments from 20 companies in 2025. Trend: 2023 $1,320 · 2024 $1,462 · 2025 $1,481
Food & beverage: $1,439Education: $43
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $196 |
| Amgen Inc. | 14 | $188 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $109 |
| Novartis Pharmaceuticals Corporation | 6 | $109 |
| Merck Sharp & Dohme LLC | 6 | $108 |
| Corcept Therapeutics | 4 | $108 |
| PFIZER INC. | 5 | $101 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $70 |
| Mannkind Corporation | 2 | $69 |
| AstraZeneca Pharmaceuticals LP | 3 | $60 |
Products named: Ozempic, JARDIANCE, LEQVIO, VERQUVO, Korlym, OTEZLA, Kerendia, AFREZZA.
Industry payments across VA — which companies pay providers there.
